Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of Klotho and Follistatin Gene Therapy
Sponsor: Minicircle
Summary
The purpose of this study is to investigate the safety and efficacy of a combination klotho and follistatin gene therapy, delivered via a nonviral plasmid in healthy adult volunteers. Additionally, this study seeks to understand the cognitive and health benefits of this gene therapy.
Official title: Evaluating the Safety and Efficacy of Injectable Combination Klotho and Follistatin Plasmid Gene Therapy in Humans -- An Interventional, Non-Placebo Controlled Pilot Phase Study
Key Details
Gender
All
Age Range
50 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-12-16
Completion Date
2026-06
Last Updated
2026-01-08
Healthy Volunteers
Yes
Conditions
Interventions
Follistatin and klotho gene therapy
Injection of nonviral plasmid-delivered follistatin and klotho gene therapy
Locations (2)
Apeiron Center
Austin, Texas, United States
Global Alliance of Regenerative Medicine (GARM) Clinic
Roatán, Bay Islands, Honduras